Arbutus Biopharma (ABUS) Tops Q3 EPS by 20c
Arbutus Biopharma (NASDAQ: ABUS) reported Q3 EPS of ($0.17), $0.20 better than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.
Arbutus Biopharma (NASDAQ: ABUS) reported Q3 EPS of ($0.17), $0.20 better than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.